BVS insider buying and SEC filings, explained
Bioventus Inc. · CIK 1665988
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$313K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Mar 11, 2026 | Sale | Michelle McMurry-Heath (Director) sold 12,000 shares at about $8.79 ($105K). Holdings down 21% to 44,997 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 13, 2026 |
| Dec 4, 2025 | Sale | Guy P. Nohra (Director) sold 10,000 shares at about $7.57 ($76K). Holdings down 8% to 116,610 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 8, 2025 |
| Nov 7, 2025 | Sale | Michelle McMurry-Heath (Director) sold 17,701 shares at about $7.42 ($131K). Holdings down 24% to 56,997 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 10, 2025 |
24 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 2, 2026, 4:12 PM ET 8-K | Earnings released (Item 2.02) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow BVS in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.